0000000000237285

AUTHOR

Bernd Grohe

showing 2 related works from this author

Kidney Stones in Primary Hyperoxaluria: New Lessons Learnt

2013

To investigate potential differences in stone composition with regard to the type of Primary Hyperoxaluria (PH), and in relation to the patient’s medical therapy (treatment naïve patients versus those on preventive medication) we examined twelve kidney stones from ten PH I and six stones from four PH III patients. Unfortunately, no PH II stones were available for analysis. The study on this set of stones indicates a more diverse composition of PH stones than previously reported and a potential dynamic response of morphology and composition of calculi to treatment with crystallization inhibitors (citrate, magnesium) in PH I. Stones formed by PH I patients under treatment are more compact and…

MaleBiomineralizationMineral Metabolism and the KidneyAnatomy and Physiology030232 urology & nephrologyCalcium oxalatelcsh:Medicine030204 cardiovascular system & hematologyPrimary hyperoxaluriachemistry.chemical_compound0302 clinical medicineMaterials ChemistryKidney StonesStone compositionChildlcsh:ScienceMineralsMultidisciplinaryMineralogyResponse to treatmentNephrologyMedicineMaterials CharacterizationResearch ArticleBiotechnologyAdultmedicine.medical_specialtyAdolescentUrologyUrinary systemMaterials ScienceUrologyengineering.materialBiomaterialsKidney CalculiYoung Adult03 medical and health sciencesmedicineHumansBiologyCalcium OxalateWhewellitelcsh:Rmedicine.diseaseSurgerychemistryHyperoxaluria PrimaryEarth Sciencesengineeringlcsh:QKidney stonesPhysiological ProcessesWeddellitePLoS ONE
researchProduct

Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies

2012

Identification of mutations in the HOGA1 gene as the cause of autosomal recessive primary hyperoxaluria (PH) type III has revitalized research in the field of PH and related stone disease. In contrast to the well-characterized entities of PH type I and type II, the pathophysiology and prevalence of type III is largely unknown. In this study, we analyzed a large cohort of subjects previously tested negative for type I/II by complete HOGA1 sequencing. Seven distinct mutations, among them four novel, were found in 15 patients. In patients of non-consanguineous European descent the previously reported c.700+5G>T splice-site mutation was predominant and represents a potential founder mutation, w…

AdultMaleAdolescentIn silicoCell Culture TechniquesMedizinGene ExpressionContext (language use)Biologymedicine.disease_causeArticlePrimary hyperoxaluriaKidney CalculiGeneticsmedicineHumansGenetic TestingGeneGenetics (clinical)Genetic testingGeneticsMutationmedicine.diagnostic_testGenetic heterogeneityOxo-Acid-LyasesMiddle Agedmedicine.diseasePhenotypePedigreeHyperoxaluria PrimaryMutationFemale
researchProduct